This report contains market size and forecasts of Computational Immunology in Global, including the following market information:
Global Computational Immunology Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Computational Immunology market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Computational Immunology companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Computational Immunology Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Computational Immunology Market Segment Percentages, By Type, 2020 (%)
Cancer Diagnosis & Therapy
Reverse Vaccinology
Immune System Modeling
China Computational Immunology Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Computational Immunology Market Segment Percentages, By Application, 2020 (%)
Allergy Prediction Databases
Analysis Resource Database
International Immunogenetics System
The Ontology of Immune Epitopes
Immune Epitope Database
Global Computational Immunology Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Computational Immunology Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Total Computational Immunology Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Computational Immunology Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
EpiVax
Novozymes Biopharma
ioGenetics
International Society of Vaccines
IMGT
Dassault Systemes
Certara
Chemical Computing Group
Compugen
Genedata AG
Insilico Biotechnology AG
Leadscope Inc
Nimbus Discovery
Strand Life Sciences
Schrodinger
Simulation Plus
Rosa & Co
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Computational Immunology Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Computational Immunology Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Computational Immunology Overall Market Size
2.1 Global Computational Immunology Market Size: 2021 VS 2027
2.2 Global Computational Immunology Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Computational Immunology Players in Global Market
3.2 Top Global Computational Immunology Companies Ranked by Revenue
3.3 Global Computational Immunology Revenue by Companies
3.4 Top 3 and Top 5 Computational Immunology Companies in Global Market, by Revenue in 2020
3.5 Global Companies Computational Immunology Product Type
3.6 Tier 1, Tier 2 and Tier 3 Computational Immunology Players in Global Market
3.6.1 List of Global Tier 1 Computational Immunology Companies
3.6.2 List of Global Tier 2 and Tier 3 Computational Immunology Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Computational Immunology Market Size Markets, 2021 & 2027
4.1.2 Cancer Diagnosis & Therapy
4.1.3 Reverse Vaccinology
4.1.4 Immune System Modeling
4.2 By Type - Global Computational Immunology Revenue & Forecasts
4.2.1 By Type - Global Computational Immunology Revenue, 2016-2021
4.2.2 By Type - Global Computational Immunology Revenue, 2022-2027
4.2.3 By Type - Global Computational Immunology Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Computational Immunology Market Size, 2021 & 2027
5.1.2 Allergy Prediction Databases
5.1.3 Analysis Resource Database
5.1.4 International Immunogenetics System
5.1.5 The Ontology of Immune Epitopes
5.1.6 Immune Epitope Database
5.2 By Application - Global Computational Immunology Revenue & Forecasts
5.2.1 By Application - Global Computational Immunology Revenue, 2016-2021
5.2.2 By Application - Global Computational Immunology Revenue, 2022-2027
5.2.3 By Application - Global Computational Immunology Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Computational Immunology Market Size, 2021 & 2027
6.2 By Region - Global Computational Immunology Revenue & Forecasts
6.2.1 By Region - Global Computational Immunology Revenue, 2016-2021
6.2.2 By Region - Global Computational Immunology Revenue, 2022-2027
6.2.3 By Region - Global Computational Immunology Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Computational Immunology Revenue, 2016-2027
6.3.2 US Computational Immunology Market Size, 2016-2027
6.3.3 Canada Computational Immunology Market Size, 2016-2027
6.3.4 Mexico Computational Immunology Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Computational Immunology Revenue, 2016-2027
6.4.2 Germany Computational Immunology Market Size, 2016-2027
6.4.3 France Computational Immunology Market Size, 2016-2027
6.4.4 U.K. Computational Immunology Market Size, 2016-2027
6.4.5 Italy Computational Immunology Market Size, 2016-2027
6.4.6 Russia Computational Immunology Market Size, 2016-2027
6.4.7 Nordic Countries Computational Immunology Market Size, 2016-2027
6.4.8 Benelux Computational Immunology Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Computational Immunology Revenue, 2016-2027
6.5.2 China Computational Immunology Market Size, 2016-2027
6.5.3 Japan Computational Immunology Market Size, 2016-2027
6.5.4 South Korea Computational Immunology Market Size, 2016-2027
6.5.5 Southeast Asia Computational Immunology Market Size, 2016-2027
6.5.6 India Computational Immunology Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Computational Immunology Revenue, 2016-2027
6.6.2 Brazil Computational Immunology Market Size, 2016-2027
6.6.3 Argentina Computational Immunology Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Computational Immunology Revenue, 2016-2027
6.7.2 Turkey Computational Immunology Market Size, 2016-2027
6.7.3 Israel Computational Immunology Market Size, 2016-2027
6.7.4 Saudi Arabia Computational Immunology Market Size, 2016-2027
6.7.5 UAE Computational Immunology Market Size, 2016-2027
7 Players Profiles
7.1 EpiVax
7.1.1 EpiVax Corporate Summary
7.1.2 EpiVax Business Overview
7.1.3 EpiVax Computational Immunology Major Product Offerings
7.1.4 EpiVax Computational Immunology Revenue in Global (2016-2021)
7.1.5 EpiVax Key News
7.2 Novozymes Biopharma
7.2.1 Novozymes Biopharma Corporate Summary
7.2.2 Novozymes Biopharma Business Overview
7.2.3 Novozymes Biopharma Computational Immunology Major Product Offerings
7.2.4 Novozymes Biopharma Computational Immunology Revenue in Global (2016-2021)
7.2.5 Novozymes Biopharma Key News
7.3 ioGenetics
7.3.1 ioGenetics Corporate Summary
7.3.2 ioGenetics Business Overview
7.3.3 ioGenetics Computational Immunology Major Product Offerings
7.3.4 ioGenetics Computational Immunology Revenue in Global (2016-2021)
7.3.5 ioGenetics Key News
7.4 International Society of Vaccines
7.4.1 International Society of Vaccines Corporate Summary
7.4.2 International Society of Vaccines Business Overview
7.4.3 International Society of Vaccines Computational Immunology Major Product Offerings
7.4.4 International Society of Vaccines Computational Immunology Revenue in Global (2016-2021)
7.4.5 International Society of Vaccines Key News
7.5 IMGT
7.5.1 IMGT Corporate Summary
7.5.2 IMGT Business Overview
7.5.3 IMGT Computational Immunology Major Product Offerings
7.5.4 IMGT Computational Immunology Revenue in Global (2016-2021)
7.5.5 IMGT Key News
7.6 Dassault Systemes
7.6.1 Dassault Systemes Corporate Summary
7.6.2 Dassault Systemes Business Overview
7.6.3 Dassault Systemes Computational Immunology Major Product Offerings
7.6.4 Dassault Systemes Computational Immunology Revenue in Global (2016-2021)
7.6.5 Dassault Systemes Key News
7.7 Certara
7.7.1 Certara Corporate Summary
7.7.2 Certara Business Overview
7.7.3 Certara Computational Immunology Major Product Offerings
7.4.4 Certara Computational Immunology Revenue in Global (2016-2021)
7.7.5 Certara Key News
7.8 Chemical Computing Group
7.8.1 Chemical Computing Group Corporate Summary
7.8.2 Chemical Computing Group Business Overview
7.8.3 Chemical Computing Group Computational Immunology Major Product Offerings
7.8.4 Chemical Computing Group Computational Immunology Revenue in Global (2016-2021)
7.8.5 Chemical Computing Group Key News
7.9 Compugen
7.9.1 Compugen Corporate Summary
7.9.2 Compugen Business Overview
7.9.3 Compugen Computational Immunology Major Product Offerings
7.9.4 Compugen Computational Immunology Revenue in Global (2016-2021)
7.9.5 Compugen Key News
7.10 Genedata AG
7.10.1 Genedata AG Corporate Summary
7.10.2 Genedata AG Business Overview
7.10.3 Genedata AG Computational Immunology Major Product Offerings
7.10.4 Genedata AG Computational Immunology Revenue in Global (2016-2021)
7.10.5 Genedata AG Key News
7.11 Insilico Biotechnology AG
7.11.1 Insilico Biotechnology AG Corporate Summary
7.11.2 Insilico Biotechnology AG Business Overview
7.11.3 Insilico Biotechnology AG Computational Immunology Major Product Offerings
7.11.4 Insilico Biotechnology AG Computational Immunology Revenue in Global (2016-2021)
7.11.5 Insilico Biotechnology AG Key News
7.12 Leadscope Inc
7.12.1 Leadscope Inc Corporate Summary
7.12.2 Leadscope Inc Business Overview
7.12.3 Leadscope Inc Computational Immunology Major Product Offerings
7.12.4 Leadscope Inc Computational Immunology Revenue in Global (2016-2021)
7.12.5 Leadscope Inc Key News
7.13 Nimbus Discovery
7.13.1 Nimbus Discovery Corporate Summary
7.13.2 Nimbus Discovery Business Overview
7.13.3 Nimbus Discovery Computational Immunology Major Product Offerings
7.13.4 Nimbus Discovery Computational Immunology Revenue in Global (2016-2021)
7.13.5 Nimbus Discovery Key News
7.14 Strand Life Sciences
7.14.1 Strand Life Sciences Corporate Summary
7.14.2 Strand Life Sciences Business Overview
7.14.3 Strand Life Sciences Computational Immunology Major Product Offerings
7.14.4 Strand Life Sciences Computational Immunology Revenue in Global (2016-2021)
7.14.5 Strand Life Sciences Key News
7.15 Schrodinger
7.15.1 Schrodinger Corporate Summary
7.15.2 Schrodinger Business Overview
7.15.3 Schrodinger Computational Immunology Major Product Offerings
7.15.4 Schrodinger Computational Immunology Revenue in Global (2016-2021)
7.15.5 Schrodinger Key News
7.16 Simulation Plus
7.16.1 Simulation Plus Corporate Summary
7.16.2 Simulation Plus Business Overview
7.16.3 Simulation Plus Computational Immunology Major Product Offerings
7.16.4 Simulation Plus Computational Immunology Revenue in Global (2016-2021)
7.16.5 Simulation Plus Key News
7.17 Rosa & Co
7.17.1 Rosa & Co Corporate Summary
7.17.2 Rosa & Co Business Overview
7.17.3 Rosa & Co Computational Immunology Major Product Offerings
7.17.4 Rosa & Co Computational Immunology Revenue in Global (2016-2021)
7.17.5 Rosa & Co Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Computational Immunology Market Opportunities & Trends in Global Market
Table 2. Computational Immunology Market Drivers in Global Market
Table 3. Computational Immunology Market Restraints in Global Market
Table 4. Key Players of Computational Immunology in Global Market
Table 5. Top Computational Immunology Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Computational Immunology Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Computational Immunology Revenue Share by Companies, 2016-2021
Table 8. Global Companies Computational Immunology Product Type
Table 9. List of Global Tier 1 Computational Immunology Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Computational Immunology Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type
EpiVax
Novozymes Biopharma
ioGenetics
International Society of Vaccines
IMGT
Dassault Systemes
Certara
Chemical Computing Group
Compugen
Genedata AG
Insilico Biotechnology AG
Leadscope Inc
Nimbus Discovery
Strand Life Sciences
Schrodinger
Simulation Plus
Rosa & Co